Endophytic upper tract urothelial carcinoma in a solitary kidney treated by cryotherapy: an unorthodox case for successful management.
Cryoablation
Nephron sparing surgery
UTUC
Upper tract urothelial carcinoma
Journal
BMC urology
ISSN: 1471-2490
Titre abrégé: BMC Urol
Pays: England
ID NLM: 100968571
Informations de publication
Date de publication:
27 Jun 2023
27 Jun 2023
Historique:
received:
05
04
2023
accepted:
22
06
2023
medline:
29
6
2023
pubmed:
28
6
2023
entrez:
27
6
2023
Statut:
epublish
Résumé
Nephroureterectomy remains the gold standard treatment for upper tract urothelial carcinoma (UTUC). Considering the high risk of developing renal function impairment after surgery, the rationale for nephron sparing approaches in treatment of UTUC has been raised. In this case, renal cryoablation was able to achieve successful oncologic control while preserving renal function during 5 years of follow up without intraoperative or post operative complications. A 79 year old male presents after three months of macroscopic hematuria. Imaging revealed a 3.6 × 3.1 × 2.7 cm endophytic mass in the interpolar region of the left kidney and an atrophic right kidney. After weighing the lesion's location with the patient's of complex medical history, he was counselled to undergo a minimally invasive percutaneous cryoablation as treatment for his solitary renal mass. A diagnostic dilemma was encountered as imaging suggested a diagnosis of renal cell carcinoma. However, the pre-ablation biopsy established an alternative diagnosis, revealing UTUC. Percutaneous cryoablation became an unorthodox treatment modality for the endophytic component of his UTUC followed by retrograde ureteroscopic laser fulguration. The patient was followed in 3 months, 6 months, then annually with cross sectional imaging by MRI, cystoscopy, urine cytology and renal function testing. After five years of follow-up, the patient did not encountered recurrence of UTUC or deterioration in renal function, thereby maintaining a stable eGFR. Although evidence for nephron-sparing modalities for UTUC is mounting in recent literature, limited data still exists on cryotherapy as a line of treatment for urothelial carcinoma. We report successful management of a low-grade UTUC using cryoablation with the crucial aid of an initial renal biopsy and long-term follow-up. Our results provide insight into the role of cryoablation as a nephron-sparing approach for UTUC.
Sections du résumé
BACKGROUND
BACKGROUND
Nephroureterectomy remains the gold standard treatment for upper tract urothelial carcinoma (UTUC). Considering the high risk of developing renal function impairment after surgery, the rationale for nephron sparing approaches in treatment of UTUC has been raised. In this case, renal cryoablation was able to achieve successful oncologic control while preserving renal function during 5 years of follow up without intraoperative or post operative complications.
CASE PRESENTATION
METHODS
A 79 year old male presents after three months of macroscopic hematuria. Imaging revealed a 3.6 × 3.1 × 2.7 cm endophytic mass in the interpolar region of the left kidney and an atrophic right kidney. After weighing the lesion's location with the patient's of complex medical history, he was counselled to undergo a minimally invasive percutaneous cryoablation as treatment for his solitary renal mass. A diagnostic dilemma was encountered as imaging suggested a diagnosis of renal cell carcinoma. However, the pre-ablation biopsy established an alternative diagnosis, revealing UTUC. Percutaneous cryoablation became an unorthodox treatment modality for the endophytic component of his UTUC followed by retrograde ureteroscopic laser fulguration. The patient was followed in 3 months, 6 months, then annually with cross sectional imaging by MRI, cystoscopy, urine cytology and renal function testing. After five years of follow-up, the patient did not encountered recurrence of UTUC or deterioration in renal function, thereby maintaining a stable eGFR.
CONCLUSION
CONCLUSIONS
Although evidence for nephron-sparing modalities for UTUC is mounting in recent literature, limited data still exists on cryotherapy as a line of treatment for urothelial carcinoma. We report successful management of a low-grade UTUC using cryoablation with the crucial aid of an initial renal biopsy and long-term follow-up. Our results provide insight into the role of cryoablation as a nephron-sparing approach for UTUC.
Identifiants
pubmed: 37370049
doi: 10.1186/s12894-023-01279-6
pii: 10.1186/s12894-023-01279-6
pmc: PMC10304237
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
111Informations de copyright
© 2023. The Author(s).
Références
Gastroenterology. 2008 Jun;134(7):1831-5
pubmed: 18486619
Urology. 2007 Oct;70(4):662-6
pubmed: 17991533
Urology. 2000 Nov 1;56(5):748-53
pubmed: 11068292
Eur Urol Oncol. 2021 Oct;4(5):792-801
pubmed: 33293235
Radiographics. 2010 Oct;30(6):1553-66
pubmed: 21071375
Lancet Oncol. 2006 Sep;7(9):735-40
pubmed: 16945768
J Urol. 1976 Jun;115(6):654-5
pubmed: 940196
J Urol. 2000 Dec;164(6):1901-4
pubmed: 11061876
Urology. 2002 Aug;60(2 Suppl 1):40-9
pubmed: 12206847
J Urol. 2010 Apr;183(4):1330-65
pubmed: 20171676
Cancer. 2009 Mar 15;115(6):1224-33
pubmed: 19156917
Cancer. 2023 Feb 1;129(3):415-425
pubmed: 36477612
World J Urol. 2017 Mar;35(3):379-387
pubmed: 27604375
BJU Int. 2008 Nov;102(9):1107-10
pubmed: 18522631
Eur Urol. 2016 Dec;70(6):1052-1068
pubmed: 27477528
J Natl Cancer Inst. 2010 May 5;102(9):605-13
pubmed: 20413742
N Engl J Med. 2004 Sep 23;351(13):1296-305
pubmed: 15385656
J Vasc Interv Radiol. 2008 Sep;19(9):1311-20
pubmed: 18725094
Clin Radiol. 2007 Apr;62(4):324-32
pubmed: 17331825
Future Oncol. 2008 Apr;4(2):257-69
pubmed: 18407738
J Urol. 2009 Oct;182(4):1271-9
pubmed: 19683266
Urol Int. 2021;105(7-8):624-630
pubmed: 33709970
Semin Dial. 2018 May;31(3):258-267
pubmed: 29624739
Semin Intervent Radiol. 2014 Mar;31(1):20-6
pubmed: 24596436
J Urol. 2008 Jun;179(6):2136-40; discussion 2140-1
pubmed: 18423719
Tech Vasc Interv Radiol. 2007 Jun;10(2):102-13
pubmed: 18070688
BJU Int. 2001 Jan;87(2):150-62
pubmed: 11167633
Eur Urol. 2021 Jan;79(1):62-79
pubmed: 32593530
Urology. 2001 Aug;58(2):174-8
pubmed: 11489692
AJR Am J Roentgenol. 2010 Jun;194(6):1620-5
pubmed: 20489104
J Vasc Interv Radiol. 2009 Oct;20(10):1329-41
pubmed: 19800542
World J Urol. 2013 Feb;31(1):141-5
pubmed: 22552732
Nephrol Dial Transplant. 2015 Aug;30(8):1300-6
pubmed: 26047631
J Urol. 2023 Jun;209(6):1071-1081
pubmed: 37096584
Radiology. 2018 May;287(2):543-553
pubmed: 29390196
J Vasc Interv Radiol. 2010 Aug;21(8 Suppl):S187-91
pubmed: 20656228